Abstract
Aims
Evidence of a role for type 2 diabetes in overall cancer risk and risk for specific types of cancer is limited in ethnic Chinese populations. We therefore investigated whether there is an association between diabetes and cancer incidence in Taiwan.
Methods
This study recruited a total of 3602 adults aged 35 years or over (average 54.9 ± 12.3 years, 52.8% women). Participants with fasting glucose ≥126 mg/dL, or taking hypoglycemic medications, were classed as having type 2 diabetes. Cancer incidence was established through regular follow-up interviews and medical records. Cox proportional hazard regression models were used to examine associations for diabetes with risk of all-cause and site-specific cancers.
Results
During a median of follow-up of 10.5 years, 275 individuals developed cancer, including 157 digestive cancers and 31 urinary cancers. Younger participants (aged < 55 years) with diabetes had a greater risk of all cancers [adjusted relative risk (RR) 3.42; 95% confidence interval (CI), 1.78–6.57], digestive cancers (adjusted RR 2.88; 95% CI 1.15–6.94) and urinary cancers (adjusted RR 13.4; 95% CI 2.70–66.3) compared with individuals in the same age group without diabetes.
Conclusions
Our results clearly demonstrate that middle-aged individuals of Chinese ethnicity with diabetes have a greater risk of all-cause cancer and specific subtypes of cancer.
Similar content being viewed by others
References
American Cancer Society (2015) Global cancer facts and figures, 3rd edn. American Cancer Society, Atlanta
Shikata K, Ninomiya T, Kiyohara Y (2013) Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 104:9–14
Wong KC, Wang Z (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 73:126–134
Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764
Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L (2014) Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 25:329–338
Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC (2013) Diabetes and pancreatic cancer. Curr Probl Cancer 37:287–292
Fang H, Yao B, Yan Y et al (2013) Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther 15:914–922
Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Nutr Sci 131:3109S–3120S
Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221
Nakamura K, Wada K, Tamai Y et al (2013) Diabetes mellitus and risk of cancer in Takayama: a population-based prospective cohort study in Japan. Cancer Sci 104:1362–1367
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202
Tseng CH (2013) Higher risk of mortality from lung cancer in Taiwanese people with diabetes. Diabetes Res Clin Pract 102:193–201
Lee YTSFC, Yang CY, Chien KL et al (2000) Chin-Shan community cardiovascular cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53:836–846
Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT (2005) Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis 183:147–155
Saito E, Charvat H, Goto A et al (2016) Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030. Cancer Sci 107:521–527
Kevin D, Burroughs SED, Carl Barrett J, Taylor Jack A (1999) Insulin-like growth factor-I: A key regulator of human cancer risk? J Natl Cancer Inst 91:579–581
Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123
Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760
Chang CH, Shau WY, Jiang YD et al (2010) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med 27:636–643
Wang M, Hu RY, Wu HB et al (2015) Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep 5:11503
Yang X, So WY, Ma RC et al (2009) Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care 32:1826–1832
Yang X, Lee HM, Chan JC (2015) Drug-subphenotype interactions for cancer in type 2 diabetes mellitus. Nat Rev Endocrinol 11:372–379
Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140
Lo SF, Chang SN, Muo CH et al (2013) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 132:182–188
Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685
Golozar A, Liu S, Lin JA, Peairs K, Yeh HC (2016) Does metformin reduce cancer risks? Methodologic considerations. Curr Diabetes Rep 16:4
Suissa S, Azoulay L (2014) Metformin and cancer: mounting evidence against an association. Diabetes Care 37:1786–1788
Acknowledgements
The study was supported by the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-002 -135 -MY3, NSC 102-2314-B-002 -080 -MY2 and NSC 100-2314-B-002 -113 -MY3).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no potential conflicts of interest in this study.
Ethical standard
The study was approved by the Institute Review Board committee of the National Taiwan University Hospital.
Human and animal rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Informed consent
Informed consent was obtained from all subjects for being included in this study, which was governed by National Taiwan University Hospital.
Additional information
Managed by Massimo Federici.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yang, WS., Chen, PC., Lin, HJ. et al. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study. Acta Diabetol 54, 455–461 (2017). https://doi.org/10.1007/s00592-017-0966-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-017-0966-1